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Vidari is an Ayurvedic herbal drug used as aphrodisiac, galactagogue and is also used in the preparation of Chyavanaprash.T u b e r s
of Ipomoea mauritiana Jacq. (Convolvulaceae), Pueraria tuberosa (Roxb. ex Willd.) DC (Fabaceae), Adenia hondala (Gaertn.)
de Wilde (Passiﬂoraceae) and pith of Cycas circinalis L. (Cycadaceae) are all traded in the name of Vidari, creating issues of
botanical authenticity of the Ayurvedic raw drug. DNA-based markers have been developed to distinguish I. mauritiana from
the other Vidari candidates. A putative 600-bp polymorphic sequence, speciﬁc to I. mauritiana was identiﬁed using randomly
ampliﬁed polymorphic DNA (RAPD) technique. Furthermore, sequence characterized ampliﬁed region (SCAR) primers (IM1F
andIM1R) were designed from the unique RAPD amplicon.The SCAR primers produced a speciﬁc 323-bp amplicon in authentic
I. mauritiana and not in the allied species.
1.Introduction
Vidari is one of the popular plant drugs of Ayurveda
and is a component of many popular and highly traded
Ayurvedic formulations like Chyavanaprash, an ancient
Indian dietary supplement. The Ayurvedic Pharmacopoeia
of India correlates “Vidari” to tubers of Pueraria tuberosa
(Roxb. ex Willd.) DC (Fabaceae) and Ipomoea mauritiana
Jacq. (Convolvulaceae) as “Kshiravidari” [1]. However, a
recent report by Venkatasubramanian et al. [2] indicates that
as per Ayurvedic descriptions they both have similar prop-
erties and can be substituted by each other. Several herbal
medicine manufacturing units also use the giant potato or I.
mauritiana (Syn. I. paniculata orI. digitata) as Vidari instead
of P. tuberosa. Vidari is useful as aphrodisiac, cardiotonic,
demulcent, diuretic, refrigerant and galactogogue [3]. It is
also used in emaciation, enteric fever and spermatorrhea
[4]. The annual trade volume of Vidari is ∼500–1000 Metric
Tonnes [5].
Ipomoea mauritiana is a branched perennial climber
with large tuberous tap roots and glabrous stems and
branches; leaves palmately 5–7 lobed; ﬂowers purple, in
pedunculate corymbose axillary panicles; fruits ovoid, four-
celled and four-valved capsules, surrounded by enlarged
ﬂeshy sepals, seed clothed with many long tawny cottony
hairs. The root tubers exude milky, sticky, latex and exhibits
annual rings when cut. This species is widely naturalized
in tropical parts of the world [6]. Taraxerol, taraxerol
acetate, umbelliferone, β-sitosterol, scopoletin and 7-O-β-
d-glycopyranosyl scopoletin (Scopolin) have been isolated
from the methanol extract of the tubers [7]. The roots are
used to increase appetite, as a galactagogue, in rejuvenative
medicine, as a stimulant, carminative and tonic [8]. Alcohol
extract of tubers is stimulant as well as depressant, and has
convalescent eﬀect on central nervous system [9, 10].
Apart from tubersof P. tuberosa andI. mauritiana,t u b e r s
of Adenia hondala (Gaertn.) de Wilde (Passiﬂoraceae) and
the pith of Cycas circinalis L. (Cycadaceae) are also traded2 Evidence-Based Complementary and Alternative Medicine
i nt h en a m eo fV i d a r i[ 5]. The Ayurvedic Pharmacopoeia of
India stipulates macro–microscopic evaluationand chemical
proﬁling of the botanical materials for quality control and
standardization [1]. Use of macro, micro and chemical
techniques for authentication has its advantages and disad-
vantages [11], while molecular markers, once standardized is
fool-proof, easy and objective [12].
Moleculargenetictoolslikebarcoding,randomampliﬁed
polymorphic DNA (RAPD) and sequence characterized
ampliﬁed region (SCAR) markers are reliable methods for
quality control of herbal materials. Fingerprints obtained by
RAPD can be employed for identiﬁcation of raw drug at the
molecularlevel[13], howeversince itisdiﬃculttoreproduce
these ﬁngerprints they are preferentially converted to SCAR
markers. Molecular marker technology proves to be valuable
tool not only for genotyping of medicinal plants but also for
detectingadulterationsandsubstitutionsinherbalmedicines
[14–17].
In our study, we have developed RAPD proﬁle of I.
mauritiana, P. tuberosa, A. hondala and C. circinalis.S u b s e -
quently, a unique DNA sequence identiﬁed from the RAPD
proﬁle of I. mauritiana was used to develop a species-
speciﬁc SCAR marker. This marker is useful to distinguish
I. mauritiana from its allied species traded as Vidari.
2.Methods
2.1. Plant Material. Field and market samples were collected
from diﬀerent geographical regions across India. Plant
samples were authenticated by qualiﬁed ﬁeld botanist and
an Ayurvedic practitioner at Foundation for Revitalization
of Local Health Traditions (FRLHT). The voucher samples
were deposited in the Herbarium and Raw Drug Repository
(FRLHT, Bangalore, India). The details of the plant samples
used in this study are presented in Table 1.
2.2. Reagents and Chemicals. CTAB (20% (w/v)), 1M Tris-
HCl (pH 8), 5M EDTA (pH 8), 5M NaCl, 3M sodium
acetate, ethanol, chloroform-isoamyl alcohol (24:1 (v/v)),
polyvinylpyrrolidone (PVP) (40000mol·wt) (Sigma), and
β-mercaptoethanol. All the chemicals used in the experi-
ments were of analytical grade. Enzymes (Taq Polymerase
and RNase A), Taq buﬀer, MgCl2 and dNTPs for polymerase
chain reaction (PCR) ampliﬁcation were purchased from
Bangalore Genei (Bangalore, India).
2.3. DNA Extraction. Dried raw plant materials were
chopped into small pieces and powdered using liquid nitro-
gen in mortar and pestle. Samples were later homogenized
using CTAB extraction buﬀer and processed as described in
theprotocolofMilligan [18].The extracted DNAwastreated
with 5μL of RNase A (10mg/mL) to remove any contam-
inating RNA. Purity and yield of DNA were checked using
UV Spectrophotometer (UV Pharmaspec 1700, Shimadzu,
Tokyo, Japan) by calculating the A260/A280 [19].
2.4. RAPD Reaction. The PCR was performed by adding
25ng of plant DNA, 2mM dNTP mix, 30pM of primer,
Table 1: Details of the plant samples used in the study.
Name of the
plant species
Accession number Place of collection
Pueraria
tuberosa
L/07/10/028 Belgaum, Karnataka
L/07/02/032 Pune, Maharastraa
L/04/07/009 Not Available
Ipomoea
mauritiana
L/08/08/014 Wayanad, Kerala
L/08/08/018 Kollukayal, Kerala
L/08/08/019 Kollukayal, Kerala
Adenia
hondala
L/07/08/009 Thiruinelli, Kerala
L/07/08/025 Kozhikode,Kerala
L/09/02/006 Kambamda, Kerala
Cycas
circinalis
L/02/01/006 Not Available
L/07/09/006 Bangalore, Karnatakaa
L/07/09/007 Bangalore, Karnatakaa
aMarket sample authenticated by botanist.
2.5μLo f1 0 × PCR buﬀer, 2.5mM MgCl2,2 . 0Uo fT a qD N A
Polymerase (Bangalore Genei, India) and made up to 25μL
with distilled water. The reactionwasperformed ina thermal
cycler (Eppendorf Master Cycler Gradient, Hamburg, Ger-
many). Reaction conditions were as follows: 94◦C—3min,
40cyclesof94◦C—30s, 36◦C—30s,72◦C—1min andaﬁnal
extension of 72◦C for 10min. PCR products were resolved in
a horizontal gel electrophoresis system (Classic CSSU1214,
Thermo Electron, MA, USA) along with standard 100-bp
ladder and λ DNA EcoR I/HindIII double digest (Bangalore
Genei, India) on a 1.2% agarose, 0.5× TBE gel. The DNA
was stained with ethidium bromide (0.5μg/mL). The gel
was visualized under UV radiation in a Camag Reprostar
(022.9610, CAMAG, Muttenz, Switzerland) and digitally
photographed (Canon, Tokyo, Japan). RAPD was performed
with40randomdecamerprimers(OPA 1–20and OPF1–20)
obtained from Operon Technologies (Alameda, CA, USA).
Electrophoretic proﬁles were analyzed for polymorphism
based on the presence and absence of DNAbands on agarose
gel. Conﬁrmation of results was done using at least three
diﬀerent samples of each species. Experiment was repeated
at least three times to conﬁrm species-speciﬁc ﬁngerprinting
pattern and reproducibility.
2.5. Cloning and Sequencing of the Polymorphic Band. The
putative marker ampliﬁed by the random primer OPA 18
was excised from 1.2% agarose gel with sterile gel slicer
and puriﬁed using the QIAquick Gel extraction kit (Qiagen,
Maryland, USA). The puriﬁed fragment was reampliﬁed
using the primer OPA 18 with the same PCR conditions,
except for the ﬁnal extension, which was increased to 20min
to facilitate cloning into TA cloning vector. About 2μL
of the puriﬁed DNA was ligated into a pDRIVE vector
and transformed into Qiagen EZ competent cells follow-
ing the manufacturer’s instructions (Qiagen, Maryland,
USA). Ten distinct white colonies were picked from the
LB/ampicillin/X-gal/IPTG plate and recombinant plasmid
was isolatedfrom eachovernightgrowncolony.ThepresenceEvidence-Based Complementary and Alternative Medicine 3
Table 2: Details of the I. mauritiana speciﬁc SCAR marker designed from the 600-bp polymorphic sequence.
Name of random
decamer primer used
Sequence of random
decamer primer
(5 -3 )
Name of the SCAR
primer
Sequence of the SCAR primer
(5 -3 )
Annealing
temperature (◦C)
OPA18 AGGTGACCGT IM1F ACTTGGGATAGGCTGACACG 60
IM1R GGTAAACCGGGATGGTTCTT 60
of insert was conﬁrmed by reamplifying the DNA using the
OPA 18 under similar RAPD conditions. The recombinant
plasmid was puriﬁed using the Quicklyse Mini prep kit
(Qiagen, Maryland, USA). DNA insert was sequenced on
an ABI 310 Automated Sequencer (Applied Biosystems, CA,
USA) using vector speciﬁc universal promoter primers SP6
(5 -CATACGATTTAGGTGACACTATAG-3 )a n dT 7( 5  -
TAATACGACTCACTATAGGG-3 ) by Bioserve Biotech-
nologies (Hyderabad, India).
2.6. SCAR Primer Designing and Validation. Based on the
sequenceofuniqueRAPDamplicon a pair ofSCARoligonu-
cleotide primers (IM 1F and IM1R), which could amplify
∼323bp of the genomic DNA of I. mauritiana was designed
(Table 2). The oligos were custom-synthesized by Bioserve
Biotechnologies (Hyderabad, India). The SCAR primer pair
was used for PCR ampliﬁcations of genomic DNA from all
the Vidari species. The reaction mixture contained 25ng
of plant DNA, 0.6mM dNTP mix, 30pM of primer, 2.5μL
of 10× PCR buﬀer, 1.5mM MgCl2,1 . 0 Uo fT a qD N A
Polymerase (Bangalore Genei, India) and made up to 25μL
with distilled water. PCR conditions for ampliﬁcation using
SCAR primers were optimized as: 95◦C for 3min; 35 cycles
of 95◦C for 35s, 60◦C for 30s, 72◦C for 45s and a ﬁnal
extension at 72◦C for 3min. The SCAR primers were
validated using three accessions each of I. mauritiana, P.
tuberosa, A. hondala and C. circinalis while repeating each
experiment three times.
3.Results
3.1. DNA Extraction and RAPD. High molecular weight
g e n o m i cD N Aw a si s o l a t e df r o mt h ef r e s ha sw e l la s
dried plant samples. The DNA extraction procedure yielded
400–600ng of DNA per 100mg of tissue. An absorbance
(A260/A280) ratio of 1.6–1.8 indicated insigniﬁcant levels
of contaminating proteins and polysaccharides. All the
40 random decamer primers used for screening, pro-
duced distinct, reproducible ﬁngerprint of I. mauritiana, P.
t u b e r o s a ,C .c i r c i n a l i sand A. hondala. OPA 18 consistently
ampliﬁed an intense 600-bp band that was unique to
I. mauritiana samples and invariant with all the three
accessions of this species tested (Figure 1). This 600-bp
amplicon was not observed in the other three species under
study.
3.2. Cloning and Sequencing of Polymorphic Band. Ipomoea
mauritiana speciﬁc 600-bp polymorphic band was cloned
1 23456789 10 11 12 13 14
600bp
Figure 1: RAPD pattern of Vidari candidates. Lane: 1—Standard
DNA marker (100-bp DNA ladder); 2–4—A. hondala;5 – 7 — C.
circinalis; 8–10—P. tuberose; 11–13—I. mauritiana; 14—Standard
DNA marker (λ DNA EcoR I/HindIII double digest).
into pDRIVE cloning vector and transformed into Qiagen
EZ competent cells. The selected white colonies contained
the required recombinant construct as was conﬁrmed by
reampliﬁcation withOPA18.The recombinant constructwas
sequenced using universal sequencing primers SP6 and T7.
The sequencing reaction yielded a 601-bp stretch with the
puriﬁed band from I. mauritiana (A 371; C 211; G 212;
T 323) (Figure 2).
3.3. Analysis of Sequence and SCAR Primer Designing. The
DNA sequence of the polymorphic band of I. mauritiana
was submitted to Genebank (Accession number: EF624353;
http://www.ncbi.nlm.nih.gov/). Homology searches were
performed within Genebank’s non-redundant database
using the Basic Local Alignment Search Tool (BLAST)
algorithm at http://www.ncbi.nlm.nih.gov/BLAST/ of the
National Center for Biotechnology Information (NCBI),
with the program BLASTN. BLAST results revealed that the
sequence did not have similarity with any known nucleotide
sequences.Basedonthesequenceoftheuniquepolymorphic
band, SCAR primers were designed using NCBI primer
blast tool (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
Primer designing was done with high stringency, so as to
give speciﬁc ampliﬁcation only with I. mauritiana samples
(Table 2).4 Evidence-Based Complementary and Alternative Medicine
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301
361
421
481
541
601
AGGTGACCGT
OPA18
CCATCCCGGT
IM1R
A
ATCATATAGC
GCTACCCAGC
TTACCAAAAG
AAACAAATTT
CACCAGCTCC
GAAATATACA
TCAAGATTAT
GATTCCGCTC
CAAAAGGGTT
ATGCAGCGAC
CAAAGGGTTT
ATCGCTGAAA
GATAGGCGAT
ATACTTGGGA
IM
TAGGCTGACA
1F
CGGCAACTTA GGCCTATCCT ATCAAACCTA GGTCGACTCG AACCTAGGCT
CTGATACCAA CTTGTAACAC CCCGGACCGG CCCTTGCCGT TAGTTACCGC
CACACCCAGA GTGGTGTCCA TCATTCCTTG ATAAATCCCA CTCCAGGTGC ACAGGCTAAA
AGAAATTACA CTCAACACTT GGACCCGCCC AATTGAAACA AAAGAGTTAT ATATCTATTT
AAGCATCGGA CTGTACATAG AACTGCCCGC CGGGCCCAAA TATGCCAGAC
CTTCCCTAAG
AACCTCACTT CTGCTCAAGC ATGCGGTACA CGGGGCCTGT GTAGGTGCCC CACACCAAGT
GCCACTCTCC CTCGAACCAC GTAATGTGGT CGAGGAATCG ACACTCCTCC
OPA18
CCCATTCTCC
TCCAAAAGAA
ACGGTCACCT
ACATCCGGAG
Figure 2: Sequence of 600-bp polymorphic region of I. mauritiana, showing binding sites of RAPD (OPA 18) marker and SCAR Marker
(IM1F and IM1R).
3.4. Validation of SCAR Primers. The designed SCAR primer
pair (IM1F and IM1R; Table 2) was used to amplify the
genomic DNA from I. mauritiana, C. circinalis, A. hondala
and P. tuberosa. A single, distinct and brightly resolved
band of 323 bp was obtained only with the accessions of
I. mauritiana, while no ampliﬁcation product was obtained
with P. tuberosa, C. circinalis and A. hondala (Figure 3).
Reduction of the annealing temperatures did not generate
anyfragmentotherthantheSCAR,conﬁrmingthespeciﬁcity
of the SCAR primer for I. mauritiana.
4.Discussion
Herbal medicine has been enjoying renaissance among the
customers throughout the world. Use of indigenous drugs
from plant origin forms a major part of complementary and
alternative medicine/traditional medicine (CAM/TM). One
of the impediments in the acceptance of herbal formulations
is the lack of standardization and quality control proﬁles.
Due to the complex nature and inherent variability of the
chemical constituents of plant-based drugs, it is diﬃcult to
establish quality control standards. Adulteration of market
samples remains a major problem in domestic and export
marketsduetoconfusingnomenclatureandlackofbotanical
identiﬁcation of traded raw drugs [20, 21]. Active chemical
composition of the herbal formulation depends on several
factors including the use of exact species [22]. Accord-
ing to World Health Organization general guidelines for
methodologies on research and evaluation of TMs, ﬁrst step
in assuring quality, safety and eﬃcacy of TMs is correct
identiﬁcation [23].
Panax (ginseng) is a representative genus of medicinal
herbs which was subjected to several methods of DNA
M M 123456789 1 0 1 2 11
323bp
Figure 3: Validation of I. mauritiana speciﬁc SCAR marker.
Lane: M—Standard DNA marker (100-bp DNA ladder); 1–3—
I. mauritiana;4 – 6 — A. hondala;7 – 9 — C. circinalis; 10–12—P.
tuberose.
analysis. The methods, applied by several research groups,
included PCR-RFLP, AFLP, RAPD, SSR, sequencing of
rDNA-ITS region and DNA barcoding. This is an example
ofhow accurate methodsfor authenticatingmedicinal plants
are necessary to modernize and standardize herbal medicine
[24, 25].
RAPD is rapid, simple and can be performed even in
the absence of prior genetic information of the plant. The
ﬁngerprint patterns obtained are consistent irrespective of
physical form, age or agroclimatic source [26].
Many technical disadvantages associated with RAPD
have, however, raised questions on its ﬁdelity as a genetic
marker technique and prevented its widespread use in
recent years. The reproducibility of RAPD is aﬀected by
DNA quality, primer and template concentration, diﬀerent
thermocyclers and even diﬀerent sources of DNA poly-
merase [15]. Therefore, subsequent conversion of RAPD to
SCAR markers, by developing longer, hence more speciﬁc
primers from RAPD sequences, has signiﬁcantly improved
the reproducibility and reliability of PCR assays [27, 28].Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: Diagrammatic representation of RAPD-SCAR marker development to authenticate I. mauritiana Jacq.
Species-speciﬁc SCAR markers have been used in several
studies to diﬀerentiate important Indian medicinal plants
from their close relatives or adulterants [17, 18]. SCAR
marker for discriminating Anthricus sylvestris, an adulterant
of Peucedanum praeruptorum and Peucedanum decursivum
(syn. Angelica decursiva) used widely in Chinese, Japanese
and Korean TM has been reported [28]. Furthermore,
development of species-speciﬁc DNA markers can increase
industrial application of the molecular techniques [27].
In our RAPD analysis, signiﬁcant genetic polymorphism
was observed among I. mauritiana and its adulterants
and substitutes. The SCAR primers designed using this
sequencevariation was found to be speciﬁc for I. mauritiana,
making the technique more stringent and speciﬁc when
compared with RAPD marker. The SCAR primers can be
used to authenticate the identity of I. mauritiana from other
traded “Vidari” candidates like C. circinalis, A. hondala and
P. tuberosa. The complete process involved in developing
RAPD-based SCAR marker for authentication of I. mauri-
tiana is summarized in Figure 4.S u c he ﬃcient, precise and
sensitive techniques are required in quality control of raw
drugs in the herbal industry.
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